IBJNews

Utility operator seeks to join Carmel-based MISO

Associated Press
September 25, 2012
Keywords
Back to TopCommentsE-mailPrintBookmark and Share

Arkansas regulators have promised to decide quickly whether Entergy Corp. has met the state's conditions to join a regional transmission group, while the utility appears to have made progress toward satisfying regulators in Mississippi.

New Orleans-based Entergy, which owns utilities in Arkansas, Louisiana, Mississippi and Texas, wants to join the Midwest Independent Transmission System Operator, or MISO. The Carmel-based group directs movement of electricity in parts of 11 Midwestern states and the Canadian province of Manitoba.

MISO has projected Entergy and its customers would save $1.4 billion over 10 years by joining. That's because MISO will make sure Entergy customers use the power that can be produced most cheaply, even if it's far away from the company's southern territory, officials say. Joining a regional transmission group could also alleviate longstanding complaints that Entergy hasn't spent enough on its grid and has used those wires to favor its own power plants over independent generators.

The Arkansas commission pledged in a Thursday order to act "expeditiously." Arkansas' approval could be key to the deal — it's the only place where the Entergy grid touches the current MISO grid.

One key issue is Arkansas' demand that regulators in each of MISO's member-states get a majority vote on where transmission lines are built and who will pay for them. Arkansas also wants those state regulators to have the power to file their views alongside those of MISO in petitions to the Federal Energy Regulatory Commission.

MISO has agreed to the filing rights, said Aldie Warnock, the group's vice president of government and regulatory affairs. But it made an alternative proposal on giving regulators a majority vote. If regulators wanted to change the group's plans, two-thirds could impose a "yellow light" where MISO would reconsider.

"While these proposals differ in some respects from the conditions..., they provide an avenue for the level of regulatory involvement in the transmission planning and transmission cost allocation consistent with that contemplated by the commission," Clair Moeller, MISO's vice president of transmission, testified in the Arkansas case.

If Arkansas regulators don't agree with that plan, Moeller said MISO would take the position that Arkansas regulators are exceeding their authority. That could be grounds for Entergy to sue the Arkansas commission in federal court.

Arkansas' regulatory staff wrote that the conditions do not overstep the commission's power: "The orders do not 'require' MISO or any other entity to take any action, as MISO repeatedly alleges. The orders state under what conditions the transfer will be approved."

Mississippi regulatory staff and Entergy reached a Sept. 17 agreement that could pave the way for that state's Public Service Commission to approve the MISO transaction. Mississippi didn't demand more power for regulators, only stating that the group should work in "good faith" to make sure transmission costs are correctly parceled out and that regulators "have an important role" in MISO. Mississippi did demand any powers that any other state wins and said it should only go through if all six Entergy subsidiaries join MISO.

The Mississippi commission's line Democrat, Brandon Presley, has been the most active in regional transmission regulation. He declined to say Tuesday whether he was satisfied with the agreement, but noted that the three commissioners don't have to "rubber stamp" the staff's agreement

Joining MISO is also important to Entergy because it wants to spin off its long-distance transmission lines to Michigan-based ITC Holdings Corp. That deal is contingent on Entergy joining a regional transmission group. On Monday, ITC and Entergy filed with the Federal Energy Regulatory Commission seeking approval for the spin-off.

ADVERTISEMENT

Post a comment to this story

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
 
Subscribe to IBJ
  1. OK Larry, let's sign Lance, shore up the PG and let's get to the finals.

  2. A couple of issues need some clarification especially since my name was on the list. I am not sure how this information was obtained and from where. For me, the amount was incorrect to begin with and the money does not come to me personally. I am guessing that the names listed are the Principal Investigators (individual responsible for the conduct of the trail) for the different pharmaceutical trials and not the entity which receives the checks. In my case, I participate in Phase II and Phase III trials which are required for new drug development. Your article should differentiate the amount of money received for consulting, for speaking fees, and for conduct of a clinical trial for new drug development. The lumping of all of these categories may give the reader a false impression of physicians just trying to get rich. The Sunshine Law may help to differentiate these categories in the future. The public should be aware that the Clinical Trial Industry could be a real economic driver for Indiana since these revenues supports jobs and new job creation. Nationally, this account for 10-20 billion which our State is missing out on to a large degree. Yes, new drug and technology development has gotten most of the attention (e.g. CTSI, BioCrossroads, etc.) However, serious money is being left on the table by not participating in the clinical trials to get those new drugs and medical devices on the market!!!! I guess that this is not sexy enough for academia.

  3. The address given for the Goldfish Swim Club is the Ace Hardware, is it closing?

  4. Out of state management and ownership. If Kite controlled it, everything would be leased. Of course, due to the roundabout, there is limited access to the south side of 116th now also. Just have to go down to the light.

  5. Hey smudge, You're opposed to arresting people for minor crimes? Sounds great! We should only focus on murders and such, right? Let's stand around and wait until someone shoots someone before we act. Whatever we do, we should never question anyone, frisk anyone, or arrest anyone unless they are actively engaged in shooting or stabbing. Very sound!

ADVERTISEMENT